Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Gains from Sales and Divestitures (2013 - 2016)

Microbot Medical posted quarterly Gains from Sales and Divestitures of $194620.0 for Q3 2016, up 122.42% year-on-year from $87500.0 in Q4 2015, and up 506.71% on a QoQ basis from $32078.0 in Q2 2016.

Microbot Medical (MBOT) has 4 years of Gains from Sales and Divestitures data on file, last reported at $194620.0 in Q3 2016.

  • For the quarter ending Q3 2016, Gains from Sales and Divestitures rose 122.42% year-over-year to $194620.0; the trailing twelve-month figure through Sep 2016 stood at $194620.0 (up 122.42% YoY), and the FY2015 full-year result was $1.5 million, changed N/A from the prior year.
  • Gains from Sales and Divestitures for Q3 2016 stood at $194620.0, up from $32078.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $1.5 million in Q4 2015 and bottomed at $22500.0 in Q3 2014.
  • The 4-year median for Gains from Sales and Divestitures is $297067.5 (2014), against an average of $408267.4.
  • The widest annual swing landed in 2015, when Gains from Sales and Divestitures jumped 288.89%; it then sank 94.63% in 2016.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $565883.0 in 2013, then soared by 50.42% to $851216.0 in 2014, then jumped by 77.42% to $1.5 million in 2015, then plunged by 87.11% to $194620.0 in 2016.
  • The last three Gains from Sales and Divestitures figures came in at $194620.0 (Q3 2016), $32078.0 (Q2 2016), and $217919.0 (Q1 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Microbot Medical 118.87 Mn 49.22 Mn 2,000.00

Historic Data

Download Data 🔒
DateValue
Sep 30, 2016 194,620.00
Sep 30, 2016 194,620.00
Jun 30, 2016 32,078.00
Jun 30, 2016 32,078.00
Mar 31, 2016 217,919.00
Mar 31, 2016 217,919.00
Dec 31, 2015 1.51 Mn
Dec 31, 2015 1.51 Mn
Sep 30, 2015 87,500.00
Sep 30, 2015 87,500.00
Jun 30, 2015 597,500.00
Jun 30, 2015 597,500.00
Mar 31, 2015 634,090.00
Mar 31, 2015 634,090.00
Dec 31, 2014 851,216.00
Dec 31, 2014 851,216.00
Sep 30, 2014 22,500.00
Sep 30, 2014 22,500.00
Jun 30, 2014 442,500.00
Jun 30, 2014 442,500.00
Mar 31, 2014 376,216.00
Mar 31, 2014 376,216.00
Dec 31, 2013 565,883.00
Dec 31, 2013 565,883.00
Sep 30, 2013 30,334.00
Sep 30, 2013 30,334.00
Jun 30, 2013 153,131.00
Jun 30, 2013 153,131.00